EDGAR Filing Documents for 0001615774-18-010760

Form DRS - Draft Registration Statement:

SEC Accession No. 0001615774-18-010760

Filing Date

2018-10-11

Accepted

2018-10-11 16:33:12

Documents

Document Format Files

Seq	Description	Document	Type	Size
1		filename1.htm	DRS	871032
2		filename2.htm	EX-3.1	101000
3		filename3.htm	EX-3	126071
4		filename4.htm	EX-4.2 1	76576
5		filename5.htm	EX-4	68092
6		filename6.htm	EX-4	68110
7		filename7.htm	EX-10.1	616926
8		filename8.htm	EX-10	167756
9		filename9.htm	EX-10	29360
10		filename10.htm	EX-10.4	277561
11		filename11.htm	EX-10	98228
12		filename12.htm	EX-10	66309
13		filename13.htm	EX-10	58806
14		filename14.htm	EX-10	64890
15	GRAPHIC	s113210_img01.jpg	GRAPHIC	117813
	Complete submission text file	0001615774-18-010760.txt		2854090

Mailing Address 2801 VIA FORTUNA, SUITE 425 AUSTIN TX 78746

Business Address 2801 VIA FORTUNA, SUITE 425 AUSTIN TX 78746 737-802-1979

TFF Pharmaceuticals, Inc. (Filer) CIK: 0001733413 (see all company filings)